Answers are grounded in this paper and cite their sources.
Tris(1,3-dichloro-2-propyl) phosphate (TDCPP) and tris(2,3-dibromopropyl) phosphate (TDBPP) are widely detected organophosphate flame retardants and environmental contaminants; however, the molecular mechanisms underlying their nephrotoxicity remain poorly defined. In this study, zebrafish larvae were used to evaluate TDCPP/TDBPP-induced renal injury, whereas HEK-293T cells were employed as an in vitro system to investigate ferroptosis-associated cellular responses and ATF3-related regulation. TDCPP and TDBPP exposure induced pronounced renal malformations and impaired filtration function in zebrafish larvae. Mechanistically, exposed cells and larvae exhibited hallmark features of ferroptosis-associated injury, including intracellular iron accumulation, excessive reactive oxygen species (ROS) production, lipid peroxidation, mitochondrial shrinkage, and lysosomal dysfunction. TDCPP/TDBPP exposure also markedly upregulated activating transcription factor 3 (ATF3) while concomitantly suppressing the SLC7A11/GPX4 antioxidant defense axis. ChIP-qPCR analysis revealed increased enrichment of ATF3 at the SLC7A11 promoter following exposure, suggesting that SLC7A11 may serve as a direct transcriptional regulatory target involved in ATF3-mediated pathway disruption. Pharmacological intervention with the ferroptosis inhibitor ferrostatin-1 (Fer-1) markedly attenuated TDCPP/TDBPP-induced renal injury, oxidative stress, organelle dysfunction, and ferroptosis-associated molecular alterations. Furthermore, ATF3 loss- and gain-of-function experiments in HEK-293T cells showed that ATF3 knockdown markedly attenuated, whereas ATF3 overexpression exacerbated, TDCPP/TDBPP-induced ferroptosis-associated cellular responses. Collectively, these findings demonstrate TDCPP/TDBPP-induced renal injury in zebrafish larvae and support the involvement of the ATF3/SLC7A11/GPX4 axis in ferroptosis-associated cellular responses to these compounds. This study provides a mechanistic basis for assessing the health risks associated with exposure to organophosphate flame retardants.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: